Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
United StatesIPO:
02 January 2013Website:
http://pharmacyte.comNext earnings report:
13 December 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | Fri, 01 Nov 2024 20:00:10 GMTDividend
Analysts recommendations
Institutional Ownership
What type of business is PharmaCyte Biotech?
PharmaCyte Biotech, Inc., a biotechnology company, develops and commercializes cellular therapies for cancer in the United States. Its cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types of cancer, including advanced and inoperable pancreatic cancer. The company develops CypCaps for pancreatic cancer and other solid cancerous tumors. It has a cooperation agreement with Iroquois Master Fund Ltd.; and license agreements with SG Austria Pte. Ltd. and Austrianova Singapore Pte. Ltd. to use the Cell-in-the-Box technology for cancer treatment. The company was formerly known as Nuvilex, Inc. and changed its name to PharmaCyte Biotech, Inc. in January 2015. PharmaCyte Biotech, Inc. was incorporated in 1996 and is headquartered in Las Vegas, Nevada.
What sector is PharmaCyte Biotech in?
PharmaCyte Biotech is in the Healthcare sector
What industry is PharmaCyte Biotech in?
PharmaCyte Biotech is in the Biotechnology industry
What country is PharmaCyte Biotech from?
PharmaCyte Biotech is headquartered in United States
When did PharmaCyte Biotech go public?
PharmaCyte Biotech initial public offering (IPO) was on 02 January 2013
What is PharmaCyte Biotech website?
https://pharmacyte.com
Is PharmaCyte Biotech in the S&P 500?
No, PharmaCyte Biotech is not included in the S&P 500 index
Is PharmaCyte Biotech in the NASDAQ 100?
No, PharmaCyte Biotech is not included in the NASDAQ 100 index
Is PharmaCyte Biotech in the Dow Jones?
No, PharmaCyte Biotech is not included in the Dow Jones index
When was PharmaCyte Biotech the previous earnings report?
No data
When does PharmaCyte Biotech earnings report?
The next expected earnings date for PharmaCyte Biotech is 13 December 2024